Dr. Souquet, Founder and CEO of SuperSonic Imagine, held the position of Chief Scientific and Technology Officer (CTO) and Senior Vice President of Philips Medical Systems worldwide from 2000 to 2005.
Jacques joined ATL Ultrasound in 1981 as principal scientist in the cardiology departement. Between 1993 and 2000 he became CTO and Senior Vice President for Product Generation.
During his career with ATL Ultrasound, between March 1989 and June 1993, Dr. Souquet served as Director of Strategic Marketing and Product Planning and Vice President for Product Generation.
Dr. Souquet received a Higher Engineering Degree from Ecole Superieure d'Electricite of Paris, France, a Ph.D. from the Orsay University of France in the field of optical memory, and a second Ph.D. from Stanford University in the field of new acoustic imaging techniques for medical ultrasound applications and nondestructive testing.
Jacques is a member of the Board of Directors of SonoSite, Inc., a leading company in the field of hand-held ultrasound imaging devices.
He is also on the Board of Directors of Median Technologies, a French company in medical computer-aided detection systems.
He is the inventor of the multiplane transesophageal echo probe, which is now used in 30% of all ultrasound echocardiography examinations.
Dr. Souquet holds 10 patents in the field of ultrasound imaging. He is the author of more than 50 technical papers and is a keynote speaker at major technical and clinical meetings worldwide.
Mathias Fink is the founder and Director the Laboratory Ondes et Acoustique at ESPCI that became in 2009 the Langevin Institute, Paris, France. He is a member of the French Academy of Science and the French Academy of Engineering and was elected in 2008 at the College de France on the Chair of Technological innovation. Mathias is known as a worldwide authority on ultrasound.
Mathias Fink is a Professor of Physics at the Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI) and at the Paris University (Denis Diderot), France.
Mathias' principle area of research is in the propagation of waves in complex media which has led to the development of a number of associated instruments. The application of these instruments covers many scientific sectors including: medical imaging and therapy, underwater acoustics, seismology, non-destructive testing, telecommunications, tactile screens and instrumentation.
Dr Fink has had a long history of collaboration with industry. He works with companies in a wide variety of sectors including: medical, aeronautics, underwater acoustics, nuclear, metallurgy and instrumentation.
He pioneered many innovative approaches such as “time-reversal mirrors” and “transient elastography”.
He holds more than 55 patents and has published more than 350 papers.
Claude Cohen-Bacrie, Executive VP and CSO of SuperSonic Imagine, held the position of cluster leader for the ultrasound departement at Philips Research USA until 2005. The post involved research into core ultrasound beamforming technology and new business ultrasound development.
Claude was senior scientist at Philips Research France between 1996 and 2002. His research interests were ultrasound vascular applications and Elastography for the breast.
Claude headed a multi-national project on breast ultrasound from 1999 to 2002 and launched several clinical investigations into new imaging protocols at various sites in France and the United States.
Claude Cohen-Bacrie received an engineering degree in electrical engineering and computer science from the Ecole Nationale Supérieure de l'Electronique et de ses Applications in 1992. He graduated with a Masters Degree in signal and image processing from the University of Orsay in 1992.
He then specialized in medical imaging and biomedical engineering at the Ecole Polytechnique de Montreal, Canada, and worked on Electrical Impedance Tomography with a specialization in lung emphysema detection.
He recieved a second Masters degree in 1994 and joined Electricite de France as a research assistant to develop innovative algorithms on Eddy current tomography for non destructive testing.
Claude Cohen-Bacrie holds 10 patents in the field of medical imaging and makes regular contributions to key scientific conferences in the field of ultrasound.
Born in 1956, Dr Grenier has been Professor of Radiology, Bordeaux since July 1990 and Chief of the “Service d’Imagerie Diagnostique et Thérapeutique de l’Adulte”, Groupe Hospitalier Pellegrin, Bordeaux since 1993.
Dr Grenier holds many prestigious appointments including: Radiology resident in Bordeaux (October 1980 - May 1986), Fellow in Radiology (Pr Broussin, Bordeaux) (May 1986 - May 1990), DEA de Biologie-Santé, Option Imagerie Fonctionnelle, Université de Bordeaux II (June 1988)
Nicolas is a member of the following Scientific Societies: Société Française de Radiologie (SFR), European Congress of Radiology (ECR), International Society of Magnetic Resonance (ISMR), Radiological Society of North America (RSNA).
Dr Grenier has served on numerous editorial and scientific boards including Revue d'Imagerie Médicale, Journal de Radiologie (since 1996), Feuillets de Radiologie (since 1996) and European Radiology Scientific Board (since 1995).
Other specialities include: Vascular Radiology, Uroradiology and Ultrasound. His research themes are Functional MR imaging of the kidney, Cellular MR imaging of the kidney and Interventional MRI with RF and focused ultrasound.
Dr Grenier has published numerous scientific papers and has been the lead clinical investigator for multicenter and pilot studies in the field of Radiology.
Gail R. ter Haar
Gail ter Haar holds an MA in Physics from Oxford University, a MSc in Medical Physics from Aberdeen University, Scotland and a PhD in Physics from the University of London (1979).
Research for her studies included the biological effects of ultrasound, which she undertook at the Physics department of Guy’s Hospital medical school, London.
In 1998 Gail was awarded a DSc in clinical medicine by the University of Oxford for her work on the safety of ultrasonic imaging and her research into the therapeutic applications of ultrasound.
Gail ter Haar is currently head of therapeutic ultrasound at the Institute of Cancer Research, Sutton, Surrey, UK. Her interests are mainly in the development of therapeutic applications of ultrasound for use in the treatment of cancer (especially high intensity focused ultrasound, HIFU), investigation of the potential of ultrasound for creating vascular occlusion for therapeutic benefit and the safety of diagnostic ultrasound techniques.
She has published 124 papers and written extensively in various medical publications.
Gail has recently been appointed visiting Professor of Therapeutic Ultrasound in the Nuffield Department of surgery at Oxford University.
She is founder and President of the International Society for Therapy Ultrasound (ISTU), chair of the European Committee for Ultrasound Radiation Safety, sits on the Safety Committee of the British Medical Ultrasound Society, and is a member of the Radiation Protection Committee of the British Institute of Radiology.
She is an honorary fellow of the American Institute for Ultrasound in Medicine and a fellow of both the Acoustic Society of America and the Institute of Engineering and Physics in Medicine.
Gail is the Associate Editor of Therapy Ultrasound for the journal Ultrasound in Medicine and Biology and is an associate editor of Ultrasonics.
Dr. Cosgrove was born in Nairobi, Kenya in 1938. He holds the post of Consultant Radiologist at Hammersmith Hospital London, and Emeritus Professor at Imperial College of Science, Technology and Medicine, London.
David Cosgrove received a BA from Oxford University in 1961; a BM BCh from St. Georges Hospital Medical School, London and Oxford University in 1963; a MRCP from London university in 1967, and a MSc in Nuclear Medicine from the University of London in 1975 (a comparison of liver scintiscans and ultrasonography in clinical diagnosis).
Dr. Cosgrove's three main themes of academic interest are:
Dr. Cosgrove is the author of key seminal papers in the field of ultrasound and is regularly invited as a keynote speaker at major conferences around the world.
James F. Greenleaf
James F. Greenleaf was born in Salt Lake City, UT in 1942. He holds a B.S. degree in Electrical Engineering from the University of Utah (1964), a M.S. degree in Engineering Science from Purdue University, Lafayette, IN (1968), and a Ph.D. in Engineering Science from the Mayo Graduate School of Medicine, Rochester, MN, and the Purdue University (1970).
Dr. Greenleaf is currently Professor of Biophysics and Associate Professor of Medicine at the Mayo Medical School, Consultant in the Department of Physiology, Biophysics, and Cardiovascular Disease and Medicine at the Mayo Foundation.
James was President of the Ultrasonics Ferroelectrics and Frequency Control Society of the IEEE between 1992 and 1993.
He holds 13 patents and received the 1986 J. Holmes Pioneer Award and the 1998 William J. Fry Memorial Lecture Award from the American Institute of Ultrasound in Medicine. He is a Fellow of IEEE, the American Institute of Ultrasound in Medicine, and the American Institute for Medical and Biological Engineering.
Dr. Greenleaf was named the Distinguished Lecturer for IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society and received the Rayleigh award in 2004.
His special field of interest is in ultrasonic biomedical science. He has published more than 327 articles and edited or written five books.
Jeffrey Colin Bamber
Born in London in 1950, Jeffrey Colin Bamber holds a PhD in Biophysics from the Institute of Cancer Research, University of London (1980), a MSc in Biophysics and Bioengineering from Chelsea College, University of London, and a BSc in Physics from the University of Kent, Canterbury (1972). He also holds the honorary position of Medical Physicist at the Royal Marsden NHS Trust since 1981 and Physicist at Hammersmith Hospitals Trust since 1996.
Dr Bamber has been team leader of the "Ultrasound and Optics Team" at the Joint Department of Physics, Institute of Cancer Research and Royal Marsden Hospital since 1986 with responsibility for managing a research team and supervising graduate students in applying ultrasonic methods in cancer medicine.
Jeffrey's fields of interest include: basic acoustic measurements on tissue and correlation with histopathology, ultrasound image speckle and texture, visual perception (psychophysics) of ultrasound images and movies, ultrasonic methods in breast cancer, assessment of tumour response, estimation of tumour and organ volume, tumour blood flow, three-dimensional ultrasound imaging, ultrasound tissue motion tracking, tissue elasticity imaging, temperature imaging, high frequency ultrasonic imaging/tissue characterization, ultrasound and optical methods in skin cancer, microbubbles as contrast agents in ultrasound and MRI, ultrasound planning guidance and monitoring of cancer treatment using high intensity focused ultrasound and conformal radiotherapy, ultrasound in radiation dosimetry, microbubbles as gene therapy vectors, and nanoparticles for molecular imaging.
Dr Bamber's articles have been featured in various speciality publications. He has written 2 theses, 66 scientific publications, 13 book chapters, 62 publications, and 134 published abstracts. He holds 4 patents.
He is a regular key note speaker at international and prestigious conferences.
Peter N. Burns is Professor and Chairman of Medical Biophysics, Professor of Radiology at the University of Toronto and Senior Scientist at Sunnybrook Health Sciences Centre, Toronto.
He holds a degree in Mathematical Physics (1973) and a PhD in Radiodiagnosis (1983) following a postgraduate fellowship in History and Philosophy of Science.
He has held faculty positions in Radiology at Yale University in Connecticut, and Thomas Jefferson University in Philadelphia. Following these posts, he moved to Toronto in 1991.
Peter worked as part of a team which first established detection of tumour blood flow with Doppler. He subsequently worked on Doppler methods for flow detection and haemodynamic measurements in the abdomen and pelvis.
In 1988 he began research with microbubbles as ultrasound contrast agents, focusing on the development of nonlinear methods such as harmonic, pulse inversion and amplitude modulation imaging as well as their clinical applications in perfusion imaging of the heart, abdomen and tumours.
He is an honory member of the Australasian Society for Ultrasound in Medicine.